Introduction: Radical prostatectomy is a more skillful procedure in kidney graft recipients. Robotic surgery can provide a useful minimally invasive tool. Objectives: The study aims to evaluate the robotic-assisted laparoscopic prostatectomy (RALP) in kidney transplant recipients, describing intra/postoperative complications, renal and oncological outcomes. Methods: This is a retrospective study conducted in a single institution of 84 RALP. Four of them were kidney transplant recipients. Side of the renal graft, clinical stage, intra/postoperative events, operating time, creatinine levels before/after intervention and oncologic follow-up were recorded. A systematic review of the literature was performed. Results: Aged 61.25 ± 7.76 years, interval between renal transplantation and RALP: 10 ± 3.16 years. Mean prostate specific antigen: 7.1 ± 2.8 ng/ml, 2 patients were cT1c and 2 cT2a. Preoperative biopsies: Gleason score 3 + 3 in 3 patients, 3 + 4 in 1 patient. Charlson comorbidity index mean was 4.82 ± 0.82. No intra/postoperative events were reported. Mean operating time: 196 ± 20.8 min. Positive surgical margins: 2/4 patients. Pathological analysis: Gleason 3 + 4 in 2 patients and Gleason 3 + 3 in the others 2. A patient developed a bladder neck sclerosis. No differences between pre/postoperative creatinine. Three patients are free of biochemical recurrence and 1 patient required adjuvant radiotherapy. Conclusion: RALP in renal transplant recipients is a safe and feasible technique for localized prostate cancer. No difference in oncological outcomes and no impairments on renal function were found.

Keywords:
Kidney transplantation, Prostatectomy, Prostatic adenocarcinoma, Prostatic carcinoma, Radical prostatectomy, Robotic prostatectomy, Robot assisted radical prostatectomy
1.
US Renal Data System: USRDS 2003 Annual Data Report: Atlas of End-Stage Renal Disease in the United States. Bethesda, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Disease, 2003.
2.
Sampaio MS, Cho YW, Qazi Y, Bunnapradist S, Hutchinson IV, Shah T: Posttransplant malignancies in solid organ adult recipients: an analysis of the U.S. National Transplant Database. Transplantation 2012;94:990-998.
3.
Tillou X, Doerfler A, Collon S, Kleinclauss F, Patard JJ, Badet L, et al: De novo kidney graft tumors: results from a multicentric retrospective national study. Am J Transplant 2012;12:3308-3315.
4.
Kasiske BL, Snyder JJ, Gilbertson DT, et al: Cancer after kidney transplantation in the United States. Am J Transplant 2004;4:905-913.
5.
Mouzin M, Bachaud JM, Kamar N, et al: Three-dimensional conformal radiotherapy for localized prostate cancer in kidney transplant recipients. Transplantation 2004;78:1496-1500.
6.
Dahlke S, Schwarz A, Bruns F, Bremer M, Miemietz M, Christiansen H, Meyer A: Pelvic radiotherapy after renal transplantation. Anticancer Res 2012;32:5083-5086.
7.
Coombs CC, Hertzfeld K, Barrett W: Outcomes in transplant patients undergoing brachytherapy for prostate cancer. Am J Clin Oncol 2012;35:40-44.
8.
Antonopoulos IM, Nahas WC, Piovesan AC, et al: Radical retropubic prostatectomy for localized prostate cancer in renal transplant patients. Urology 2008;72:1362-1365.
9.
Robert G, Elkentaoui H, Pasticier G, et al: Laparoscopic radical prostatectomy in renal transplant recipients. Urology 2009;74:683-687.
10.
Maestro MA, Gómez AT, Alonso Y Gregorio S, Ledo JC, de la Peña Barthel J, Martínez-Piñeiro L: Laparoscopic transperitoneal radical prostatectomy in renal transplant recipients: a review of the literature. BJU Int 2010;105:844-848.
11.
Thomas AA, Nguyen MM, Gill IS: Laparoscopic transperitoneal radical prostatectomy in renal transplant recipients: a review of three cases. Urology 2008;71:205-208.
12.
Doerfler A, Vaessen C, Gosseine PN, et al: Laparoscopic radical prostatectomy in kidney transplant patient: our first experience - a case report. Transplant Proc 2009;41:713-715.
13.
Shah KK, Ko DS, Mercer J, et al: Laparoscopic radical prostatectomy in a renal allograft recipient. Urology 2006;68:672.e5-e7.
14.
Moreno Sierra J, Núñez Mora C, Galante Romo MI, Prieto Nogal S, López García Asenjo J, Silmi Moyano A: [Da Vinci robot assisted radical prostatectomy: one year experience at the Hospital Clínico San Carlos]. Arch Esp Urol 2008;61:385-396.
15.
Jhaveri JK, Tan GY, Scherr DS, et al: Robot-assisted laparoscopic radical prostatectomy in the renal allograft transplant recipient. J Endourol 2008;22:2475-2479.
16.
Wagener N, Nyarangi-Dix JN, Teber D, Zeier M, Hohenfellner M: Applicability of robot-assisted laparoscopic radical prostatectomy in renal allograft recipients. Transplant Proc 2012;44:1287-1292.
17.
Kleinclauss FM, Neuzillet Y, Tillou X, et al: Morbidity of retropubic radical prostatectomy for prostate cancer in renal transplant recipients: multicenter study from renal transplantation committee of French urological association. Urology 2008;72:1366-1370.
18.
Smith DL, Jellison FC, et al: Robot-assisted radical prostatectomy in patients with previous renal transplantation. J Endourol 2011;25:1643-1647.
19.
Polcari AJ, Allen JC, Nunez-Nateras R, et al: Multicenter experience with robot-assisted radical prostatectomy in renal transplant recipients. Urology 2012;80:1267-1272.
20.
Smith DL, Jellison FC, Heldt JP, Tenggardjaja C, Bowman RJ, Jin DH, Chamberlin J, Lui PD, Baldwin DD: Robot-assisted radical prostatectomy in patients with previous renal transplantation. J Endourol 2011;25:1643-1647.
21.
Ghazi A, Erturk E, Joseph JV: Modifications to facilitate extraperitoneal robot-assisted radical prostatectomy post kidney transplant. JSLS 2012;16:314-319.
22.
Le Clerc QC, Lecornet E, Leon G, Rigaud J, Glemain P, Branchereau J, Karam G: Technical feasibility of robot-assisted laparoscopic radical prostatectomy in renal transplant recipients: results of a series of 12 consecutive cases. Can Urol Assoc J 2015;9:E490-E493.
23.
Ghazi A, Erturk E, Joseph JV: Modifications to facilitate extraperitoneal robot-assisted radical prostatectomy post kidney transplant. JSLS 2012;16:314-319.
© 2016 S. Karger AG, Basel
2016
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.